SITAXA M XR 50+500 (Sitagliptin (50mg) + Metformin (500mg))

Sitaxa M XR 50+500 is an extended-release tablet formulated with a combination of two active ingredients that work together to help manage elevated blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. Effectively controlling blood glucose is essential to prevent severe complications related to diabetes, such as potential kidney impairment and vision loss, and may also lower the risk of cardiovascular events like heart attacks and strokes. This medication may be taken on its own or in conjunction with additional diabetes treatments as directed by a healthcare provider. To optimize its effectiveness, it is recommended to take Sitaxa M XR 50+500 with meals, as this can minimize gastrointestinal discomfort. Adherence to a consistent dosing schedule at the same time each day is crucial, and discontinuation should only occur under the guidance of a healthcare professional. Alongside medication, maintaining a balanced diet and engaging in regular physical activity are vital components of diabetes management, as lifestyle choices significantly influence blood sugar control. Side effects may include gastrointestinal disturbances, respiratory infections, and headaches, with the potential for hypoglycemia, particularly if combined with other diabetes medications. It is important to disclose any history of kidney, liver, or heart conditions, as well as high alcohol consumption to your healthcare provider before starting this medication. Pregnant or breastfeeding individuals should seek professional medical advice regarding the use of this treatment. Regular monitoring of kidney function and blood sugar levels is essential during the treatment period.